Table 2.
Clinical features selected in machine learning algorithm.
| Demographics | Comorbidities | Laboratory Data | Containment Medications |
|---|---|---|---|
| Age | Hypertension | Blood urea nitrogen | ACEI |
| Gender | Transient ischemic attack | Creatinine | ARB |
| Smoking | Ischemic stroke | White blood cell counts | Alpha blocker |
| Alcohol consumption | Hemorrhagic stroke | Hemoglobin | Beta blocker |
| Dementia | Sodium | CCB | |
| Diabetes mellitus | Potassium | Warfarin | |
| Gout | Chloride | DOAC | |
| Myocardial infarction | Calcium | Aspirin | |
| Coronary artery disease | Phosphate | Plavix | |
| CHF | HCO3 | Nitrate | |
| Atrial fibrillation | C-reactive protein | Statin | |
| Chronic liver disease | Albumin | Diuretic | |
| Cirrhosis | Alanine transaminase | Spironolactone | |
| Peptic ulcer disease | Aspartate transaminase | Metformin | |
| COPD | Alkaline phosphatase | Sulfonylurea | |
| Asthma | Gamma-glutamyl transferase | Meglitinide | |
| PAOD | Total bilirubin | SGLT2 inhibitor | |
| Autoimmune disease | HbA1c | GLP1 receptor agonist | |
| Cancer | Glucose | DPP4 inhibitor | |
| Valvular heart disease | Uric acid | Thiazolidinedione | |
| ICU admission | Cholesterol | Alpha-glucosidase inhibitor | |
| Use of mechanical ventilators | LDL-C | Insulin | |
| Use of inotropes | HDL-C | NSAID | |
| INR | COX-2 inhibitor | ||
| aPTT | Proton pump inhibitor | ||
| D-dimer | Steroid | ||
| LDH | Allopurinol | ||
| NT-proBNP | Febuxostat | ||
| Benzbromarone |
Abbreviations: CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; PAOD, peripheral arterial occlusive disease; ICU, intensive care unit; HCO3, bicarbonate; HbA1c, hemoglobin A1c; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein-cholesterol; INR, international normalized ratio; aPTT, activated partial thromboplastin time; LDH, lactate dehydrogenase; NT-proBNP, N-terminal pro-brain natriuretic peptide; ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; DOAC, direct oral anticoagulant; SGLT2, sodium-glucose cotransporter 2 inhibitor; GLP1, glucagon-like peptide-1; DPP4, Dipeptidyl peptidase-4; NSAID, nonsteroidal anti-inflammatory drug; COX-2, cyclooxygenase-2.